A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
Journal of Antimicrobial Chemotherapy · 2026
DOI: 10.1093/jac/dkag111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Sarah Hendrickx und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Wilrijk (Antwerp) 2610, Belgium. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Drug Discovery, Kinetoplastida, Drug Development. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen, Swedish Research Council Formas, Kempe Foundations.
Abstract (Originalsprache)
Neglected tropical diseases such as leishmaniasis, Chagas disease, sleeping sickness and animal trypanosomiasis remain a significant global health challenge. This part of the roadmap outlines a streamlined path for progressing from lead identification to a drug development candidate, tailored to the specific needs of kinetoplastid infections. Besides the medicinal upscaling of synthesis, this review highlights key experiments in pharmacology in non-rodent species, toxicology, pharmacokinetics and pharmaceutics. These include but are not limited to early evaluation of safety using refined in vitro and in vivo methods to enhance predictive value, bioavailability and distribution to target tissues, and formulation strategies leveraging various delivery systems to optimize efficacy and safety. Environmental toxicity is also addressed proactively, for which in silico tools are presented. Collectively, this roadmap provides a practical, scalable approach to deliver high-quality drug candidates capable of addressing the urgent needs for kinetoplastid diseases (Figure 1).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Wilrijk (Antwerp) 2610, Belgium.
- Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, Umeå 907 36, Sweden.
- Laboratory of Adaptive Biodynamics, Research Unit of Environmental and Evolutionary Biology, Institute of Life, Earth, and Environment, University of Namur, Namur 5000, Belgium.
- Department of Zoology, Stockholm University, Stockholm 114 18, Sweden.
- School of Biological Sciences, Monash University, Clayton, Victoria 3800, Australia.
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.
ORCID-Profile: Katrien Van Bocxlaer, Guy Caljon
Förderung
- Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen
- Swedish Research Council Formas
- Kempe Foundations
Zitieren
APA
Hendrickx, S., Ilbeigi, K., Thoré, E. S. J., Bertram, M. G., Calvo-Alvarez, E., Cintesun, S., Olías-Molero, A. I., Corral, M. J., Mateo-Barrientos, M., Estaquier, J., Pomel, S., Alunda, J. M., Gul, S., Van Bocxlaer, K., Frézard, F., Tavares, J., Cordeiro Da Silva, A., Costi, M. P., Maes, L., & Caljon, G. (2026). A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag111
Vancouver
Hendrickx S, Ilbeigi K, Thoré ESJ, Bertram MG, Calvo-Alvarez E, Cintesun S, et al. A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag111
BibTeX
@article{Hendrickx2026,
author = {Hendrickx, Sarah and Ilbeigi, Kayhan and Thoré, Eli S J and Bertram, Michael G and Calvo-Alvarez, Estefanía and Cintesun, Sener and Olías-Molero, Ana Isabel and Corral, María Jesús and Mateo-Barrientos, Marta and Estaquier, Jérôme and Pomel, Sébastien and Alunda, José María and Gul, Sheraz and Van Bocxlaer, Katrien and Frézard, Frédéric and Tavares, Joana and Cordeiro Da Silva, Anabela and Costi, Maria Paola and Maes, Louis and Caljon, Guy},
title = {A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
doi = {10.1093/jac/dkag111}
}
EUVIMED